Two RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties.
Maeshima Y, Colorado PC, Kalluri R.
Maeshima Y, et al.
J Biol Chem. 2000 Aug 4;275(31):23745-50. doi: 10.1074/jbc.C000186200.
J Biol Chem. 2000.
PMID: 10837460
Free article.
Tumstatin (alpha3(IV)NC1 domain) is one such novel molecule with distinct anti-tumor properties and possesses an N-terminal (amino acids 54-132) anti-angiogenic and a C-terminal (amino acids 185-203) anti-tumor cell activity (Maeshima, Y., et al. 2000) J. Biol. Chem …
Tumstatin (alpha3(IV)NC1 domain) is one such novel molecule with distinct anti-tumor properties and possesses an N-terminal (amino acids 54- …